What clinical trials are available for locally advanced Pancreatic Cancer

Clinical Trials for Locally Advanced Pancreatic Cancer

I appreciate your question about clinical trial options. Let me explain what's happening in this area and what you should know about finding trials that might be right for you.

Understanding Locally Advanced Pancreatic Cancer

First, some context: locally advanced pancreatic cancer means the tumor has grown into nearby structures (like blood vessels or organs) but hasn't spread to distant sites. This is an important distinction because it affects treatment options.

Current Clinical Trial Approaches

According to the NCCN Guidelines for Patients: Pancreatic Cancer, clinical trials have become increasingly standard in pancreatic cancer care. Here are the main research directions for locally advanced disease:

1. Combination Chemotherapy + Radiation + Immunotherapy

Recent research is exploring combinations that go beyond traditional treatment. For example, studies are testing:

• Chemotherapy (like FOLFIRINOX or gemcitabine/nab-paclitaxel)
• Radiation therapy (including newer techniques like SBRT - stereotactic body radiation therapy)
• Immunotherapy agents to enhance the body's immune response

According to research presented at ASCO GI 2023, a Phase I trial combined GVAX (a vaccine), nivolumab (immunotherapy), and BMS-813160 for locally advanced disease. Early results showed the combination appears safe and doesn't delay surgery.

2. Neoadjuvant Approaches (Treatment Before Surgery)

The goal here is to shrink the tumor so surgery becomes possible. Trials are testing:

• Sequential chemotherapy regimens (FFX followed by Gem/NabP)
• Combined chemotherapy + radiation
• Novel combinations with targeted or immune therapies

3. Radiation Technique Comparisons

Research is comparing different radiation approaches:

• SBRT (stereotactic body radiation therapy) - focused, high-dose radiation
• IMRT (intensity-modulated radiation therapy) - more traditional approach

Studies show SBRT may have better tolerability with comparable effectiveness.

How to Find Trials for YOUR Situation

According to the NCCN Guidelines, here are specific questions to ask your oncology team:

1. "Do you recommend that I consider a clinical trial for treatment?"
2. "How do I find clinical trials in which I can participate?"
3. "What are the treatments used in the clinical trial?"
4. "What are the risks and benefits of this treatment?"
5. "What side effects should I expect and how will they be managed?"
6. "How long will I be in the clinical trial?"
7. "Will I be able to get other treatment if this doesn't work?"
8. "How will you know if the treatment is working?"

Where to Search for Trials

• ClinicalTrials.gov - The official U.S. registry (search "locally advanced pancreatic cancer")
• Let's Win Pancreatic Cancer Trial Finder - Specifically curated pancreatic cancer trials
• Your cancer center's molecular tumor board - Many major centers have teams that match patients to trials based on tumor genetics

Important Context

According to Dr. [removed] Strickler (Duke University, in the Cancer Patient Lab webinar "Navigating Pancreatic Cancer"), genetic testing of your tumor is now recommended by national guidelines. This molecular profiling can identify whether your cancer has specific mutations (like KRAS, BRCA, or others) that might make you eligible for targeted therapy trials—which could be more effective and have fewer side effects than traditional chemotherapy alone.

Key Takeaway

The landscape for locally advanced pancreatic cancer is evolving rapidly. Your oncologist should discuss:

• Whether neoadjuvant (pre-surgery) treatment is appropriate for you
• Whether your tumor has been genetically tested
• What clinical trials match your specific situation
• Whether you're a candidate for surgery after treatment

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.